Migraine Headache with Nausea Study | Central Kentucky Research
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here: amrllc.com.

CKRA News

Migraine Headache with Nausea Study

  • February 21, 2019

Central Kentucky Research Associates, An AMR Company, is conducting a clinical research study of an investigational medication for migraine headaches with nausea.

Duration: Approximately 2 months

# of visits to CKRA: 2

Compensation: If you qualify you may receive compensation for time and travel.

Note: You may qualify if you are between the ages of 18 and 75 years old, have been diagnosed by a physician as having migraines, and experience nausea during migraine attacks. Other criteria also apply.

For more information please go to www.MigraineNauseaTrial.com or call CKRA at 859-264-8999.